“Top-notch science that leads to a treatment” Story 2017 may become a very exciting year for Patricia Biasutto, sepofarsen captain. Her work, developing a novel RNA therapy for Leber congenital amaurosis 10, has progressed steadily. The team expects to start a first clinical trial this year. mars 31, 2017
Why AI, Why Now Community news ProQR's mission-aligned strategy for scaling AI across Axiomer RNA editing drug discovery and development - and the team now joining to build it out septembre 23, 2026